Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience Letters

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neulet.2008.05.067PMID 18555604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin

  2007cited by this paper
• Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.

  2007cited by this paper
• Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.

  2007cited by this paper
• Glial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation.

  2007cited by this paper
• Targeted Antioxidative and Neuroprotective Properties of the Dopamine Agonist Pramipexole and Its Nondopaminergic Enantiomer SND919CL2x [(+)2-Amino-4,5,6,7-tetrahydro-6-lpropylamino-benzathiazole Dihydrochloride]

  2006cited by this paper
• Apomorphine‐induced activation of dopamine receptors modulates FGF‐2 expression in astrocytic cultures and promotes survival of dopaminergic neurons

  2006cited by this paper
• Proteasomal dysfunction in sporadic Parkinson's disease

  2006cited by this paper
• Proteasome inhibitor–induced model of Parkinson's disease

  2006cited by this paper
• Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins.

  2006cited by this paper
• D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease

  2006cited by this paper
• D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.

  2006cited by this paper
• Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2‐receptor agonist pramipexole

  2006cited by this paper
• Pramipexole protects against H2O2-induced PC12 cell death

  2005cited by this paper
• Dopamine D3 receptor‐preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons

  2005cited by this paper
• Pramipexole protects against apoptotic cell death by non‐dopaminergic mechanisms

  2004cited by this paper
• Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia.

  2004cited by this paper
• Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.

  2004cited by this paper
• Apoptosis and Parkinson's disease.

  2003cited by this paper
• Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

  2003cited by this paper
• Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats.

  2002cited by this paper
• Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole.

  2001cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

  2000cited by this paper
• Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes.

  2000cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

  1998cited by this paper
• A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue.

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• First of two parts

  1997cited by this paper
• The etiology of Parkinson's disease with emphasis on the MPTP story

  1996cited by this paper
• Standardized methods to bioassay neurotrophic factors for dopaminergic neurons.

  1996cited by this paper
• l‐DOPA Up‐Regulates Glutathione and Protects Mesencephalic Cultures Against Oxidative Stress

  1996cited by this paper
• Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells.

  1994cited by this paper
• β/A4‐evoked degeneration of differentiated SH‐SY5Y human neuroblastoma cells

  1994cited by this paper
• K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.

  1992cited by this paper

• Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?

  2023cites this paper
• Glutathione and Related Molecules in Parkinsonism

  2021cites this paper
• Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• Neuron-Astrocyte Interactions in Parkinson’s Disease

  2020cites this paper
• Dopamine D3 receptor: a neglected participant in Parkinson Disease pathogenesis and treatment?

  2019influential citation
• COMPARISON EFFECT BETWEEN PEGAGAN (Centella asiatica) EXTRACT AND PRAMIPEXOLE TOWARD LOCOMOTOR ACTIVITIES, α - SYNUCLEIN, AND NRF2 EXPRESSION IN ZEBRAFISH PARKINSON MODEL

  2019cites this paper
• Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase

  2018cites this paper
• Antidepressant‐like effect of pramipexole in an inflammatory model of depression

  2017cites this paper
• Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture.

  2016cites this paper
• Dopamine D3 agonists in the treatment of Parkinson's disease.

  2015cites this paper
• Purines in Parkinson’s: Adenosine A2A Receptors and Urate as Targets for Neuroprotection

  2015cites this paper
• Electrophysiology and pharmacology of tandem domain potassium channel TREK-1 related BDNF synthesis in rat astrocytes

  2014cites this paper
• Protection by inosine in a cellular model of Parkinson's disease.

  2014cites this paper
• The secretome signature of reactive glial cells and its pathological implications.

  2013cites this paper
• The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.

  2013cites this paper
• Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129

  2013cites this paper
• The Extent of Neurodegeneration and Neuroprotection in Two Chemical In Vitro Models Related to Parkinson’s Disease is Critically Dependent on Cell Culture Conditions

  2013cites this paper
• Characterization of the secretome of human tooth germ stem cells (hTGSCs) reveals neuro-protection by fine-tuning micro-environment.

  2013cites this paper
• The Investigation of a TIMP-1-modulated Glial-Derived Factor Affecting Neuroblastoma Cell Death

  2013cites this paper
• Protection of dopaminergic cells by urate requires its accumulation in astrocytes

  2012cites this paper
• Award Number: W81XWH-11-1-0150 TITLE: Protection by Purines in Toxin Models of Parkinson's Disease PRINCIPAL INVESTIGATOR:

  2012cites this paper
• Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.

  2012cites this paper
• Role of Pramipexole in Delaying L-dopa Induced Dyskinesia and Enhancing the Response to L-dopa in 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian Mice

  2012cites this paper
• Dopamine Receptors, Motor Responses, and Dopaminergic Agonists

  2011cites this paper
• Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype.

  2011cites this paper
• Differentiation and Neuro-Protective Properties of Immortalized Human Tooth Germ Stem Cells

  2011cites this paper
• Neuroprotective Role of Dopamine Agonists: Evidence From Animal Models and Clinical Studies

  2011cites this paper
• Brain-derived neurotrophic factor and its receptors in Bergmann glia cells.

  2011cites this paper
• Protective effect of the dopamine D(3) receptor agonist (7-OH-PIPAT) against apoptosis in malignant peripheral nerve sheath tumor (MPNST) cells.

  2010cites this paper
• Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation.

  2010cites this paper
• Activation of Phosphatidylinositol-Linked D1-Like Receptor Modulates FGF-2 Expression in Astrocytes via IP3-Dependent Ca2+ Signaling

  2009influential citation
• Etiopathogenesis and treatment of Parkinson's disease.

  2009cites this paper
• Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole

  2009cites this paper